Your SlideShare is downloading. ×
0
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
 Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

625

Published on

In this multi-sponsor report, BioInformatics LLC will conduct an in-depth exploration of projected lab budgets and sources of funding by region, and the implications of these findings for the life …

In this multi-sponsor report, BioInformatics LLC will conduct an in-depth exploration of projected lab budgets and sources of funding by region, and the implications of these findings for the life science tools market in the coming year.

The objective of this study is to assess sources of funding, the competitive landscape and market opportunities for life science tools companies. From the perspective of end-users, the goals of this assignment will be to:

-Understand current sources of funding from government/stimulus/private foundation grants, distribution time frame and how labs initiate applications for funding.
-Compare and contrast FY2013 (actual), and FY2014 (projected) average lab budgets in total by broad product category, region and market segment; providing directional information for FY2014.
-Estimate scientists' budget for purchases and anticipated purchases in instrumentation and consumables, examining trends across key product categories.
-Assess how optimistic scientists are regarding funding and the future of life science research.

Contents, pricing and deadline
-----------------------------------
BioInformatics LLC will deliver an in-depth analysis of the study's significant findings and their implications for your 2014 marketing strategy. A hard copy and an electronic version (PDF) of the final report will be provided to each sponsor. The final report will consist of the following sections:

SECTION 1 - Overview and Regional Comparisons
SECTION 2 - Market Analysis and Funding Situation for the United States
SECTION 3 - Market Analysis for Funding Situation in Europe
SECTION 4 - Market Analysis for Asia
SECTION 5 - Study Methodology and Demographics
SECTION 6 - Verbatim Comments from Survey Respondents

Due to the high level of interest in this topic expressed by multiple life science suppliers and to defray the costs inherent in such a complex study, we are offering the report as a multi-sponsor opportunity.

The fee for this study is $15,000 for each sponsor, but the report you will receive would be a $50,000-$60,000 investment for a single company to commission it individually.

Please note that the deadline for inclusion in the October 2013 study is Friday, October 18, 2013.*

For more information on this report, contact:

Mary Follin
Marketing/Sales Manager
BioInformatics LLC
703.778.3080 ext. 13
m.follin@gene2drug.com
www.gene2drug.com

*We will require a minimum of 6 sponsors to move forward with this study, so if you could indicate your intention to participate as soon as you've made a decision, that will be helpful to us for planning purposes.

Published in: Business, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
625
On Slideshare
0
From Embeds
0
Number of Embeds
5
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. gene2drug.com Life Science Industry Market Research
  • 2. Life Science Industry Market Researchgene2drug.com Why We’re Here • Economic landscape • Report scope • Being a sponsor 2
  • 3. Life Science Industry Market Researchgene2drug.com3 Your Feedback (Type questions in the box on the side of your screen)
  • 4. Life Science Industry Market Researchgene2drug.com About BioInformatics LLC 4 § A full-service market research firm since 1994: •  Published and syndicated reports •  Consulting and strategy development •  Expert interviews •  Focus groups •  Surveys •  RateMyProduct™
  • 5. Life Science Industry Market Researchgene2drug.com About BioInformatics LLC § Conducting market research exclusively on scientific markets: • Lab products • Analytical instrumentation • Biotechnology research & bioprocessing • Drug discovery & development • Molecular diagnostics 5 manufacturing  &  material  science chemical,  food  &  beverage environmental  testing clinical  diagnostics pharmaceutical agriculture  biotech laboratory  products life  sciences
  • 6. Life Science Industry Market Researchgene2drug.com About BioInformatics LLC 6 Project team includes scientists, statisticians and business analysts. Instant access to a 74,000+ member expert scientific panel. An Overview of Your Epigenetic Research © 2009 BioInformatics, LLC www.gene2drug.com 3-17 * Totals are based on number of times an item was selected. * Percentages are based on number of respondents. 68% 57% 55% 47% 23% 20% 14% 10% 10% 5% 0% 10% 20% 30% 40% 50% 60% 70% 80% Gene regulation Disease mechanisms Biomarkers Basic biology of epigenetics Therapeutic targets Stem cells Genomic imprinting Transgenerational epigenetic inheritance Tissue repair/regeneration X chromosome inactivation Respondents 200 Gene regulation 135 Disease mechanisms 115 Biomarkers 110 Basic biology of epigenetics 94 Therapeutic targets 46 Stem cells 41 Genomic imprinting 27 Transgenerational epigenetic inheritance 21 X chromosome inactivation 10 Question 9* (check all that apply) Conduct market research for major suppliers in the industry.
  • 7. Life Science Industry Market Researchgene2drug.com Introduction Robin Rothrock, Ph.D. Director of Publications 7
  • 8. Life Science Industry Market Researchgene2drug.com8 Overview of the Economic Landscape
  • 9. Life Science Industry Market Researchgene2drug.com9
  • 10. Life Science Industry Market Researchgene2drug.com United States § Sequester § Uncertainty regarding healthcare reform § Changes in molecular diagnostic tests coding and reimbursement § Flat to declining pharmaceutical R&D budgets 10
  • 11. Life Science Industry Market Researchgene2drug.com Europe § Continued fiscal austerity § Changes in healthcare institutions and funding § Funding of research is complex and multilayered § Cross-border collaboration is increasing § Leading institutions are taking action to be competitive with the U.S. in recruiting postdocs from India and China 11
  • 12. Life Science Industry Market Researchgene2drug.com China § Government and commercial investment: >$260 billion over the next 5 years •  500 universities •  More than 150,000 life science graduates per year •  Four innovation clusters •  7,500 life science companies •  200 life science incubators •  100 life science parks 12 §  “Sea turtles” return §  Growth in pharmaceutical market
  • 13. Life Science Industry Market Researchgene2drug.com A New Normal for Life Science Research § Slow global recovery § Unfavorable research funding § ñ pricing pressure § Growth in Asian markets may be slowing 13
  • 14. Life Science Industry Market Researchgene2drug.com14 Report Scope
  • 15. Life Science Industry Market Researchgene2drug.com Objectives § Understand current sources of funding § Compare and contrast FY2013 (actual), and FY2014 (projected) average lab budgets § Estimate scientists’ budget for purchases and anticipated purchases in instrumentation and consumables § Take the pulse of the life science community regarding funding and the future of life science research 15
  • 16. Life Science Industry Market Researchgene2drug.com Framework Secondary research § An extensive review of relevant research councils, funding agencies and private funding sources § United States and Europe Primary research § Quantitative survey administered to life scientists in the United States, Europe and Asia § Have budget authority § Sample size ≅ 1,000 § 75% academic/gov’t and 25% life science industry 16
  • 17. Life Science Industry Market Researchgene2drug.com Questionnaire § Funding & Budgets •  Current sources of funding •  Average lab budgets (2013 and 2014)  •  Average lab budgets for instrumentation •  Average lab budgets for consumables •  Percent budget allocation for overhead and salaries •  Laboratory headcount § Techniques •  Current usage •  Explore adoption of new products/techniques in the next 12 months •  Purchase of instrumentation (actual in 2013 and expected in 2014) •  Identify new and emerging technologies 17
  • 18. Life Science Industry Market Researchgene2drug.com Customer Sentiment 18 Will my project be funded next year?
  • 19. Life Science Industry Market Researchgene2drug.com Product Categories § Instrumentation for… •  Cell-based analysis (flow cytometers, high content analyzers, all microscopes, high throughput screening and analysis systems, etc.) •  Genome analysis (thermal cyclers, real-time PCR instrumentation, microarray instrumentation, NGS, capillary electrophoresis, etc.) •  Protein analysis (chromatography, electrophoresis, mass spectrometry, label-free detection, calorimetry, NMR, CD, etc.) § Consumables •  Cell-based analysis kits and reagents (cell culture media and reagents, antibodies, cell biology kits, etc.) •  Genome analysis kits and reagents (enzymes, kits, ladders, nucleic acid purification and separation products, oligonucleotides [primers, RNAi], etc.) •  Protein purification and separation kits and reagents (chromatography media, electrophoresis matrices, protein ladders, etc.) •  General laboratory chemicals, plasticware, glassware and disposables 19
  • 20. Life Science Industry Market Researchgene2drug.com Cell-Based Techniques § Bacteria Culture § Cell-Based Assays § Confocal Microscopy § Eukaryotic Cell/Tissue Culture § Flow Cytometry § Fluorescence Microscopy § Gene Expression Analysis § High Content Screening § High-Throughput Screening (HTS) § Immunohistochemistry § Light Microscopy § Stem Cell Culture/Analysis 20
  • 21. Life Science Industry Market Researchgene2drug.com Genomics Techniques § Classical End-Point PCR § Cloning/Molecular biology Techniques § DNA/RNA Microarrays § Genotyping § Next Generation Sequencing § Real-Time PCR § RNAi (including siRNA, miRNA) § Sanger DNA Sequencing § Single Nucleotide Polymorphism 21
  • 22. Life Science Industry Market Researchgene2drug.com Protein Techniques §  2-D Gel Electrophoresis §  Calorimetry (including ITC, DSC) §  Enzyme-linked Immunosorbent Assay (ELISA) §  Label-Free Detection/Analysis (Including Biosensors, SPR, etc.) §  Light Scattering (MALS, DLS) §  Mass Spectrometry §  Multiplex Bead Assays §  Protein Purification & Separation §  Protein Structural Analysis (NMR, CD, etc.) §  Western Blotting 22
  • 23. Life Science Industry Market Researchgene2drug.com Deliverable 23 UK, France, Germany, Spain, Italy, Switzerland & Scandinavia China, India, South Korea, Singapore & Japan
  • 24. Life Science Industry Market Researchgene2drug.com24 Why this report?
  • 25. Life Science Industry Market Researchgene2drug.com Share Gain/Share Protect Strategies § Where is the growth? § Funding trends? § Are researchers pitching their grants to follow the money? 25
  • 26. Life Science Industry Market Researchgene2drug.com How You Can Use It § Check assumptions § Make decisions § Forecast revenues § Identify potential growth 26
  • 27. Life Science Industry Market Researchgene2drug.com Benefits of Being a Sponsor 27 Cost Control Start-up Time Expertise Objectivity Efficiency
  • 28. Life Science Industry Market Researchgene2drug.com Fees 28 $80,000-$100,00 Cost of sponsorship is $15,000
  • 29. Life Science Industry Market Researchgene2drug.com29 Questions?
  • 30. Life Science Industry Market Researchgene2drug.com Contact Mary Follin Marketing/Sales Manager 703.778.3080 x13 m.follin@gene2drug.com 30 Lab Budgets and Sources of Funding in 2014 Multi-Sponsor Research December 2013 CALL TODAY to BECOME A SPONSOR!

×